ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.33
1.50%
US Tech 100
19,167.20
2.31%
S&P 500
5,638.94
2.13%
US Dollar vs CAD
1.43865
0.00%
Bitcoin
84,396.24
0.06%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. MEI Pharma Inc (MEIP) Share Price

MEI Pharma Inc

MEI Pharma Inc (MEIP)

NASDAQ
2.309
0.009
(0.39%)
Closed March 16 3:00PM
Delayed by 15 minutes
2.309
0.00
(0.00%)
After Hours: 4:16PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.309
Bid
2.26
Ask
3.26
Volume
1,639
2.30 Day's Range 2.34
2.30 52 Week Range 4.16
Market Cap
15.385M
Previous Close
2.30
Open
2.32
Last Trade
1
@
2.33
Last Trade Time
Financial Volume
US$ 3,786
VWAP
2.3102
Average Volume (3m)
17,924
Shares Outstanding
6,662,857
Dividend Yield
-
PE Ratio
0.87
Earnings Per Share (EPS)
2.67
Revenue
65.3M
Net Profit
17.78M

About MEI Pharma Inc

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical deve... MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.meipharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
MEI Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MEIP. The last closing price for MEI Pharma was US$2.30. Over the last year, MEI Pharma shares have traded in a share price range of US$ 2.30 to US$ 4.16.

MEI Pharma currently has 6,662,857 shares outstanding. The market capitalization of MEI Pharma is US$15.32 million. MEI Pharma has a price to earnings ratio (PE ratio) of 0.87.

Ask ADVFN Intelligence (AI)

MEIP Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
March 07 2025
MEIP (0.39%)

Form 8-K - Current report
Edgar (US Regulatory)
February 12 2025
MEIP (0.39%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
February 12 2025
MEIP (0.39%)

Form 8-K - Current report
Edgar (US Regulatory)
January 31 2025
MEIP (0.39%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
December 20 2024
MEIP (0.39%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
December 20 2024
MEIP (0.39%)

Form 8-K - Current report
Edgar (US Regulatory)
November 25 2024
MEIP (0.39%)

Form 8-K - Current report
Edgar (US Regulatory)
November 14 2024
MEIP (0.39%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.081-3.389121338912.392.452.362222.40589109CS
4-0.2367-9.298031975492.54572.792.375262.48867081CS
12-0.161-6.518218623482.472.912.3179242.53307146CS
26-0.721-23.7953795383.033.292.3317482.77884077CS
52-1.801-43.81995133824.114.162.3451313.21573871CS
156-33.691-93.58611111113638.82.3102750210.38532785CS
260-14.691-86.41764705881791.52.3106415231.06656035CS

MEIP - Frequently Asked Questions (FAQ)

What is the current MEI Pharma share price?
The current share price of MEI Pharma is US$ 2.309
How many MEI Pharma shares are in issue?
MEI Pharma has 6,662,857 shares in issue
What is the market cap of MEI Pharma?
The market capitalisation of MEI Pharma is USD 15.32M
What is the 1 year trading range for MEI Pharma share price?
MEI Pharma has traded in the range of US$ 2.30 to US$ 4.16 during the past year
What is the PE ratio of MEI Pharma?
The price to earnings ratio of MEI Pharma is 0.87
What is the cash to sales ratio of MEI Pharma?
The cash to sales ratio of MEI Pharma is 0.24
What is the reporting currency for MEI Pharma?
MEI Pharma reports financial results in USD
What is the latest annual turnover for MEI Pharma?
The latest annual turnover of MEI Pharma is USD 65.3M
What is the latest annual profit for MEI Pharma?
The latest annual profit of MEI Pharma is USD 17.78M
What is the registered address of MEI Pharma?
The registered address for MEI Pharma is 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the MEI Pharma website address?
The website address for MEI Pharma is www.meipharma.com
Which industry sector does MEI Pharma operate in?
MEI Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M

MEIP Discussion

View Posts
Awl416 Awl416 8 months ago
MEI Pharma to Consider Strategic Alternatives
👍️0
chumfm chumfm 11 months ago
Raiders took all the cash with the dividend.Now the company share price is tanking,with no soft landing.No revenue streams and coffers are empty.Very difficult too see a bright future,here.All these trials take time and money.We will need an infusion of cash soon.Good luck and good trading.
👍️0
Monksdream Monksdream 12 months ago
MEIP under $5
👍️0
BurgerKing82 BurgerKing82 12 months ago
Pretty stagnant on this board for awhile ..Could be a good sign?
👍️0
philaya philaya 1 year ago
Sols some ...
No fun .
.
👍️0
philaya philaya 1 year ago
only 2 ask size 100 shares...
no selling all holding.
👍️0
philaya philaya 1 year ago
Added before er...
Easy bounce.
👍️0
kzivann kzivann 2 years ago
Out. May recover but R/S concern is here. Flip but still watching. Usually don't say much but since I told you I got some, figured I should.

MEIP
👍️0
kzivann kzivann 2 years ago
Doing a little. Risking a part of prior trades. Got only 1500 on that mini dip but didn't hit my larger .23 bid.


MEIP
👍️0
INFINITI INFINITI 2 years ago
What’s your take on Today thinking if loading
👍️0
kzivann kzivann 2 years ago
Lead drug. FDA issue. Continuing trails in Japan with partner. Has cash to continue with two other drugs here.

MEIP
👍️0
INFINITI INFINITI 2 years ago
Why did it drop so much
👍️0
kzivann kzivann 2 years ago
Bidding now. A little below current bid.

MEIP
👍️0
INFINITI INFINITI 2 years ago
Oops bottom cat bounce here
👍️0
INFINITI INFINITI 2 years ago
Biotin cat bounce here
👍️0
kzivann kzivann 2 years ago
Good move Friday $$$

MEIP
👍️0
rudyboy rudyboy 2 years ago
Who the fuck is selling all those shares.... institutions?
👍️0
kzivann kzivann 3 years ago
Little flips add up.

MEIP
👍️0
dfrank1988 dfrank1988 3 years ago
MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights
👍️0
kzivann kzivann 3 years ago
Again.

MEIP
👍️0
DD-214 DD-214 3 years ago
MEIP - MEI Pharma, Inc. (NASDAQ:MEIP) Shares Purchased by Sigma Planning Corp

Sigma Planning Corp lifted its holdings in MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) by 164.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 418,950 shares of the company’s stock after purchasing an additional 260,600 shares during the quarter. Sigma Planning Corp owned about 0.32% of MEI Pharma worth $252,000 as of its most recent SEC filing.

https://www.defenseworld.net/2022/07/11/mei-pharma-inc-nasdaqmeip-shares-purchased-by-sigma-planning-corp.html
👍️0
CAN8IENS CAN8IENS 3 years ago
I had a buddy tell me to buy this. Bought at .52. Completely forgot about it. What's up with the move?
👍️0
kzivann kzivann 3 years ago
Nice move.

MEIP
👍️0
Jess070283 Jess070283 3 years ago
Next huuuuge runner!!!
👍️0
kzivann kzivann 3 years ago
Keeps going up.

MEIP
👍️0
kzivann kzivann 3 years ago
Another nice move. Buy some, sell some, hold some.

MEIP
👍️0
kzivann kzivann 3 years ago
Dip but .51 not filled

MEIP
👍️0
kzivann kzivann 3 years ago
Premarket volume.

meip
👍️0
kzivann kzivann 3 years ago
Premarket volume.

meip
👍️0
Virgowhiteguy Virgowhiteguy 3 years ago
MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022

https://marketwirenews.com/news-releases/mei-pharma-and-kyowa-kirin-report-new-clinical-data--7831482843146987.html?t=389791
👍️0
kzivann kzivann 3 years ago
Again.

MEIP
👍️0
kzivann kzivann 3 years ago
Another nice bounce.

MEIP
👍️0
kzivann kzivann 3 years ago
Decent move..

MEIP
👍️0
kzivann kzivann 3 years ago
Very nice. Can MEIP breakout?
👍️0
kzivann kzivann 3 years ago
Bouncing off new low.

MEIP
👍️0
kzivann kzivann 3 years ago
Nice little run..

MEIP
👍️0
green maschine green maschine 3 years ago
Good morning $MEIP! In @ .64
👍️0
kzivann kzivann 3 years ago
Nice move. Occasionally lucky. Bought yesterday.

MEIP
👍️0
ErnieBilco ErnieBilco 3 years ago
But there may be hope after avg down

MEI Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $5.44, representing an 859.9% upside.
👍️0
ErnieBilco ErnieBilco 3 years ago
Very very poorly
👍️0
Bigstud is here Bigstud is here 3 years ago
Well, How your 98s work out?
👍️0
ErnieBilco ErnieBilco 3 years ago
Where is the bottom on this thing?
👍️0
DD-214 DD-214 3 years ago
Glutton for punishment.. back in @.537 average..
👍️0
DD-214 DD-214 3 years ago
Out @.589, lol that was quick.. i’ll keep an eye on it and jump back in when the timing is right..
👍️0
DD-214 DD-214 3 years ago
Took a new position on MEIP, 50k @.593 average.
👍️0
willlbone willlbone 3 years ago
MEIP MEIP roadrunner goes off the cliff.
👍️0
stockweiser stockweiser 3 years ago
The price is better
👍️0
ErnieBilco ErnieBilco 3 years ago
Ouch, 25% loss in less than a day - Guess .98 wasn't the right entry point last night.
👍️0
willlbone willlbone 3 years ago
Bid 50 cents
👍️0
ErnieBilco ErnieBilco 3 years ago
Well, Let's see how my .98s work out going forward from here.
👍️0

Your Recent History

NASDAQ
MEIP
MEI Pharma
TG
4JZ1
SPDR Series
NASDAQ
FCZZX
Bmo Concentrated Global ...
USOTC
QYOUF
QYou Media (QB)
NASDAQ
ADSEW
ADD TEC Energy
NASDAQ
FUHXX
Phillips Hager & North C...
NASDAQ
FCWCX
Bmo Brookfield Global Re...
NASDAQ
PDSN
Powerdsine
NASDAQ
FDUS
Fidus Investment
TG
INDB
Lyxor Asset Management L...
NASDAQ
IXAQ
IX Acquisition
NASDAQ
CENX
Century Aluminum
NASDAQ
IRETS
Investors Real Estate Trust
COIN
DEGOUSD
dego.finance
NASDAQ
RDAC
Rising Dragon Acquisition
DOWI
DJEFNT
DJ Emerging Markets Fina...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads